• Email Us: [email protected]
  • Contact Us: +1 718 874 1545
  • Skip to main content
  • Skip to primary sidebar

Medical Market Report

  • Home
  • All Reports
  • About Us
  • Contact Us

A Drug To Treat Frostbite Is Finally Available

February 24, 2024 by Deborah Bloomfield

The ConversationFrostbite can occur at temperatures just below freezing (-0.55°C), though at such temperatures frostbite is typically mild and no permanent damage will result. But what happens if you live and work somewhere where it gets much colder?

As a Canadian, I am used to seeing news reports during cold snaps warning people to avoid going outdoors due to frostbite being possible “in under a minute”.

Advertisement

Until now, there have been no approved therapies for severe frostbite. But on February 14 2024, the US Food and Drug Administration (FDA) announced that it had approved the very first drug to treat frostbite.

Frostbite is evolution’s response to prolonged or extreme cold, causing blood vessels to constrict and blood flow to slow in the extremities. This keeps blood flowing in the vital organs warm, increasing the chance of surviving in the extreme cold.

The downside is this can result in permanent damage to the fingers, toes and parts of the face, sometimes requiring amputation of the affected body parts. (Frostbite has resulted in some odd traditions, such as the Sourtoe Cocktail in Dawson City where customers drink a cocktail containing an amputated frostbitten toe.)

Repurposed drug

The new drug, called iloprost (brand name Aurlumyn), is repurposed. This means that it was not originally developed to treat frostbite. In this case, it is used to treat high blood pressure within the lungs.

Advertisement

Repurposed drugs have already passed important (and expensive) human safety testing and are therefore much cheaper (about US$40-80 million or £32-64 million) to develop for additional medical issues versus creating a new drug (about US$1-2 billion), making drug repurposing an attractive way to find new treatments.

Many drugs have been tried as potential treatments for severe frostbite. However, iloprost is the first to be put through a clinical trial where patients with severe frostbite were randomly allocated to receive iloprost or not.

The study found that 60 percent of the patients who did not receive iloprost had injuries sufficiently severe to warrant amputation, versus 0 percent of the patients who received iloprost.

While the total number of patients tested in this study was small at 47, the combined facts that there are no other approved pharmaceutical treatments for frostbite and the impressive digit-saving results found in this randomised human trial were sufficient to convince the FDA to approve this repurposed therapy for severe frostbite.

How it works

Iloprost works by expanding the blood vessels (called a vasodilator) of patients and stopping blood clots from forming. As frostbite causes constriction of blood vessels, this suggests one mechanism through which iloprost helps heal frostbitten tissue is by reversing this constriction.

However, whenever blood flow is reintroduced in such tissue, it can paradoxically worsen the injury and cause more damage. This is called “reperfusion injury” and is largely caused by a sudden influx of oxygen causing oxidative stress. Interestingly, iloprost is not only a vasodilator but also reduces oxidative stress, suggesting this dual mechanism of action could help explain its impressive potential as a frostbite treatment.

Frostbite is a common condition in colder parts of the world with one Finnish study finding that 1.1 percent of the Finnish population experiences severe frostbite every year and 12.9 percent suffer from mild frostbite. As the injuries from frostbite can be serious, the approval of a drug that significantly reduces the risk of life-altering amputations of patients’ fingers, toes and noses will certainly be welcome news to many.

However, an unintended consequence may be that the Sourtoe Cocktail Club has a harder time finding new frostbitten toes to add to its collection in the coming years.

Advertisement

Steven R. Hall, Lecturer in Pharmacology, Lancaster University

This article is republished from The Conversation under a Creative Commons license. Read the original article.

Deborah Bloomfield
Deborah Bloomfield

Related posts:

  1. Soccer – FIFA backs down on threat to fine Premier clubs who play South American players
  2. U.S. House passes abortion rights bill, outlook poor in Senate
  3. UBS clients raise $650 million for biggest yet biotech impact fund
  4. We’ve Breached Six Of The Nine “Planetary Boundaries” For Sustaining Human Civilization

Source Link: A Drug To Treat Frostbite Is Finally Available

Filed Under: News

Primary Sidebar

  • Unethical Experiments: When Scientists Really Should Have Stopped What They Were Doing Immediately
  • The First Humans Were Hunted By Leopards And Weren’t The Apex Predators We Thought They Were
  • Earth’s Passage Through The Galaxy Might Be Written In Its Rocks
  • What Is An Einstein Cross – And Why Is The Latest One Such A Unique Find?
  • If We Found Life On Mars, What Would That Mean For The Fermi Paradox And The Great Filter?
  • The Longest Living Mammals Are Giants That Live Up To 200 Years In The Icy Arctic
  • Entirely New Virus Detected In Bat Urine, And It’s Only The 4th Of Its Kind Ever Isolated
  • The First Ever Full Asteroid History: From Its Doomed Discovery To Collecting Its Meteorites
  • World’s Oldest Pachycephalosaur Fossil Pushes Back These Dinosaurs’ Emergence By 15 Million Years
  • The Hole In The Ozone Layer Is Healing And On Track For Full Recovery In The 21st Century, Thanks To Science
  • First Sweet Potato Genome Reveals They’re Hybrids With A Puzzling Past And 6 Sets Of Chromosomes
  • Why Is The Top Of Canada So Sparsely Populated? Meet The “Canadian Shield”
  • Humans Are In The Middle Of “A Great Evolutionary Transition”, New Paper Claims
  • Why Do Some Toilets Have Two Flush Buttons?
  • 130-Year-Old Butter Additive Discovered In Danish Basement Contains Bacteria From The 1890s
  • Prehistoric Humans Made Necklaces From Marine Mollusk Fossils 20,000 Years Ago
  • Zond 5: In 1968 Two Soviet Steppe Tortoises Beat Humans To Orbiting Around The Moon
  • Why Cats Adapted This Defense Mechanism From Snakes
  • Mother Orca Seen Carrying Dead Calf Once Again On Washington Coast
  • A Busy Spider Season Is Brewing: Why This Fall Could See A Boom Of Arachnid Activity
  • Business
  • Health
  • News
  • Science
  • Technology
  • +1 718 874 1545
  • +91 78878 22626
  • [email protected]
Office Address
Prudour Pvt. Ltd. 420 Lexington Avenue Suite 300 New York City, NY 10170.

Powered by Prudour Network

Copyrights © 2025 · Medical Market Report. All Rights Reserved.

Go to mobile version